CPRIT PDR — Texas Therapeutics Company
Funds Texas oncology companies with revenue-sharing support as therapies move toward commercialization.
The CPRIT Texas Therapeutics Company RFA is one of four Product Development Research mechanisms administered by the Cancer Prevention and Research Institute of Texas, which allocates approximately $70 million per fiscal year to product development awards. The Therapeutics RFA funds Texas-based for-profit companies developing novel cancer therapeutics at or near the IND-enabling or Phase 1 stage. E…
Cancer therapeutics development by Texas-based for-profit companies at or near IND filing or Phase 1, covering preclinical proof of concept through early clinical trials.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline